CDMO trends: Drug development and industry consolidation

Of course, in a shifting regulatory environment with evolving customer demands, CDMOs must always be thinking about what is next.

With the emergence of new technologies and the demand for pharmaceutical products increasing, the outsourcing sector is adapting in order to meet current healthcare standards and expectations. While these trends continue to improve the customer experience, they also present new opportunities for the wider industry. For example, access to new innovative technologies that allow companies to develop both new and existing drugs.

Mark Quick, Executive Vice President of Corporate Development, at Recipharm discusses the key trends shaping the outsourcing sector. He also sheds light on how the CDMO market can prepare to effectively respond to future customer demands and regulatory requirements.  

Read the full article here: